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Protective immunity to bacteriae that can multiply
intracellularly such as mycobacterium and salmonella is
known to depend on cell-mediated immunity (1). The
major effector mechanism of cell-mediated immunity is
thought to be the activation of infected macrophages by
type-1 cytokines, particularly interferon- γ (IFN-γ). IFN-γ
is produced by natural killer and Th1 cells and its
production is up-regulated by interleukine-12 (IL-12),
which is released by macrophages as well as dendritic
cells. It has been reported that IL-12 dependent
interferon- g secretion is essential in the control of
mycobacterial infections (2-6). In addition, studies of
patients with severe infections arising from poorly
pathogenic mycobacterium and salmonella species have
revealed genetic mutations in type-1 cytokine (IL-12p40)
or type-1 cytokine receptor (IFN-gR1, IFN-γR2, IL12Rb1) genes (1).
A 101/2-year-old boy was referred to our hospital for
chronic diarrhoea, abdominal pain and weight loss.
Weight loss of 6 kg had occurred in the 6 weeks prior to
his admission. He had been hospitalised in another
hospital for 15 days with diagnoses of giardiasis and
anemia and had been given metronidazol and iron
treatment. No improvement had been observed in his
symptoms after treatment.
According to his medical history, he had suffered from
chickenpox and mumps in early childhood. His
immunisation status was up to date at the time of
admission, and he had been given BCG vaccines twice (at
birth and at 7 years of age) and a live measles vaccine.
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The patient was healthy until 7 years of age, when he was
diagnosed with pulmonary tuberculosis in another
hospital and was treated with isoniazid, rifampicine and
streptomycine.
The parents were found to be first cousins, with 3
healthy daughters. The third child of the family (female)
died at the age of 11/2 years because of severe persistent
diarrhoea.
His weight was 24 kg (3rd-10th centile), and his
height was 137 cm (50th-75th centile). He had two BCG
scars. The physical examination was otherwise normal
except for hepatomegaly, 5 cm below the costal margin.
Laboratory studies revealed a WBC count of 7200/µL
with 54% neutrophils, 40% lymphocytes, and 6%
monocytes; the hemoglobin level was 8.3 g/dL; MCV, 69
fL; platelet count, 490,000/mL; erythrocyte
sedimentation rate, 56 mm/hour; C-reactive protein, 5,1
mg/dL; total protein, 5,3 g/dL; albumin, 2.7 g/dL; ALT,
39 IU/L; AST, 73 IU/L; LDH, 470 IU/L; protrombin time,
13 sec; APTZ, 30 sec; and blood urea, 31 mg/dL. ANA,
antigliadin antibody, and anti-endomysium antibodies
were all negative. Stool and blood cultures were also
negative. Anti-EBV, CMV and Herpes simplex 1 virus
antibodies (IgG) were found to be negative. The anti-HIV
antibody was negative. A tuberculin skin test was
negative. His chest x-ray was normal. Cultures for three
consecutive early morning gastric aspirates for
acidoresistant bacteriae (ARB) were negative. A
computed tomography scan of the abdomen
demonstrated hepatomegaly, multiple paraaortic and
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mesenteric lymphadenopathies, and dilatations and a mild
mucosal thickening of the wall of the ileum, caecum and
ascending colon.
For differential diagnoses of lymphoma or intestinal
tuberculosis, excisional biopsy samples from lymph nodes
and a needle biopsy sample from the liver obtained by
exploratory laparotomy demonstrated well-organized
granulomata with large numbers of ARB inside
macrophages. The patientÕs family history revealed no
known cases of tuberculosis. Both parents underwent
Mantoux tests with negative results. Since the
pathological findings were suggestive of an atypical
mycobacterial infection, the patient was administered
antimycobacterial treatment consisting of rifampin (15
mg/kg per day), ethambutol (15 mg/kg per day),
clarithromycin (25 mg/kg per day) and ciprofloxacin (40
mg/kg per day). The results of lymphocyte phenotyping
and a burst test by flow cytometry and serum
immunoglobulins were normal in the patient, ruling out
classical immunodeficiencies such as severe combined
immunodeficiency and chronic granulomatous disease.
Peripheral blood mononuclear cells in the patient did not
express IL-12 receptor β1 (IL-12Rβ1) on the cell surface
(Dr. Jean-Laurent Casanova, Paris, France). IFN-γ
receptor (IF-γR) expression was normal. He was shown
to have IL-12Rβ1 deficiency. Our patient did not exhibit
any susceptibility to other viral, bacterial, or fungal
pathogens. However, the mycobacterial infection
diagnosed after the second BCG vaccine might have been
disseminated BCG infection. It has been reported that
milder forms of BCG infections are observed in IL12Rβ1-deficiencies (1).
Two weeks after the onset of antimycobacterial
therapy, the diarrhoea and abdominal pain disappeared.
One month after the onset of therapy, rifampin and then
ciprofloxacine were withdrawn because of the elevation
of transaminases, and streptomycine was added to the
treatment. Although the general clinical status of the
patient was clinically stable, multiple cervical, axillary and
inguinal lymphadenopathies (the largest one was 1.5 x
1.5 cm in diameter) appeared during the end of the
second month of the treatment. Lymph node biopsies also
demonstrated ARB and granulomata. Although
mycobacteria was grown from the sample obtained from
lymph nodes, microbiological identification was not
possible until appropriate gene probes were available.
When clofazimine became available, the therapy was
changed to clarithromycine, ethambutol and clofazimine
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and recombinant IFN-γ treatment (50 µg/m2, SC, three
times a week) was started.
Despite this aggressive treatment, the lymph nodes
remained enlarged and the spleen enlarged progressively.
The WBC (2.000/mm3) and platelet (68.000/mm3)
counts decreased. With the diagnosis of hypersplenism, a
total splenectomy was carried out. The pathological
examination of the spleen showed well-developed
granulomata with large numbers of ARB inside
macrophages. The WBC and platelet counts rapidly
increased after the splenectomy. Six months after
hospitalisation, the causative agent was identified as
mycobacterium fortuitum-chelonae complex, and
treatment was arranged according to an antibiotic
sensitivity test (to amikacin, doxycycline and clofazimine).
The microorganism was resistant to streptomycin,
rifampicin, isoniazid and ethambutol. One month after
this treatment, the patient gained weight (about 8 kg),
and the hepatomegaly and lymphadenomegalies
disappeared. Liver function tests, CRP and ESR were
normal.
The
paraaortic
and
mesenteric
lymphadenopathies also disappeared. Amikacin (after it
had been used for a total of 2 months) and IFN-γ (after it
had been used for a total of 6 months) were stopped. It
was decided that the doxycycline and clofazimine
treatments should be continued for a total of 6 months.
IL-12Rβ1 deficiency has recently been reported in a
total of 7 individuals with mycobacterial infections (2, 3).
Insufficient IFN-γ production appears to be the main
pathogenic mechanism in IL-12Rβ1- deficient patients.
IFN-γR receptor deficiencies can also lead to infection
with mycobacteria of low-grade virulence (7-9). In
contrast to complete IFN-γR deficiencies, in which the
onset of infection is before three years of age and
affected children develop severe and mostly fatal
infections, patients with complete IL-12Rβ1- deficiency
often develop milder, although still severe, infections.
These patients resemble children with partial IFN-γR
deficiency. Children with complete IL-12Rβ1- deficiency
and partial IFN-γR deficiency have mature granulomas,
unlike children with complete IFN-γR deficiency. The
milder phenotype is probably attributable to IL-12
independent pathways of IFN-γ production.
In conclusion, patients with disseminated atypical
mycobacterial infections must be examined for IL-12 or
IFN-γ receptor deficiencies unless they have other wellknown immunodeficiencies.
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